Why Do Precise Lesion Measurements Directly Impact Dermatology Revenue?

Image
Precise lesion measurements directly impact dermatology revenue because coding, reimbursement levels, and medical necessity depend on accurate documentation of lesion size and complexity. In dermatology, even small  measurement differences can change procedure codes, alter reimbursement amounts, and trigger  claim denials  if the  documentation does not support the billed service. Accurate measurement is not just a clinical detail—it is a financial safeguard. Why Are Lesion Measurements Critical in Dermatology Billing? In dermatology billing , many procedure codes are selected based on lesion size. Excision, destruction, and biopsy codes often depend on the lesion's diameter, including its margins. Incorrect or incomplete measurements can result in: Downcoding Underpayment Overbilling risks Increased audit exposure Precise measurement ensures proper revenue capture . How Do Coding Guidelines Depend on Lesion Size? CPT coding for lesion removal...

Price Transparency for Durable Medical Equipment


Price transparency refers to the extent to which information is obtainable. It is when all parties in trading are aware of the product pricing i.e. awareness and knowledge of the bid price and asks price at various price levels, along with the quantities of any good or service involved. This also results in discrepancies in the billing and coding, thus affecting
 revenue cycle management.

DME refers to equipment such as oxygen supplies, wheelchairs, knee braces, etc. It has to be prescribed by a medical practitioner and the person buys this equipment from a DME provider or sometimes, the doctor himself calls a DME company for delivering it straight to the patient's home. This is where the price transparency has a catch. A knee brace could cost anywhere from a range of $250 to $1500 from two different DME companies. DME billing then gets erroneous due to double bills and unsuitable expenses.

Effects of Price Transparency-
DME billing takes a course on patients also as sometimes insurances have a set limit on what they can pay for the DME equipment. If the cost goes beyond that limit, the patient ends up paying himself. Overpayments occurring in DME billing are mainly due to price transparency being available on the web and various catalog prices. Again, due to changes in methods of production, market variations, and product innovations, Medicare ends up paying much more overall for DMEPOS (paying the market price for dressings-surgical but overpaying for wheelchairs). Especially in expensive and specialized medical devices, there are very few competitors; devices such as implantable cardioverter defibrillators (ICDs), pacemakers, etc. fall under the label of "differentiated oligopoly" category. Manufacturers do not set a single price for such products and charge different prices from different buyers (sellers have control over the prices they sell at).

To get more information about Price Transparency for DME click here: https://bit.ly/3SQ7rYZ.

Comments

Popular posts from this blog

How to Reduce Days in A/R with Smart Denial Management Strategies

Understanding the Differences Between Claim Denials and Rejections in Medical Billing

How Outsourced Medical Billing Can Improve Your Practice’s Profitability